3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
23
Myelodysplastic Syndromes
6
Leukemia, Myelomonocytic, Chronic
3
Neoplasms
2
Myeloproliferative Disorders
2
Hodgkin Disease
2
GATA2 Deficiency
2
Anemia, Refractory, with Excess of Blasts
2
Pathologic Complete Response
1
Neoplasm Metastasis
1
Lymphoma, T-Cell
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Monocytic, Acute
1
Leukemia, Megakaryoblastic, Acute
1
Leukemia, Erythroblastic, Acute
1
Leukemia
1
Immunoblastic Lymphadenopathy
1
Hematologic Neoplasms
1
Enteropathy-Associated T-Cell Lymphoma
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
asciminib
7
Cyclophosphamide
6
fludarabine phosphate
5
fludarabine
4
nilotinib
3
Whole-Body Irradiation
3
Mycophenolic Acid
3
Imatinib Mesylate
3
venetoclax
2
Thiotepa
2
Tacrolimus
2
Granulocyte Colony-Stimulating Factor
2
Filgrastim
2
Dasatinib
2
Cyclosporine
2
treosulfan
1
thymoglobulin
1
selinexor
1
ponatinib
1
olverembatinib
1
midostaurin
1
merphos
1
gilteritinib
1
bosutinib
1
blinatumomab
1
aldesleukin
1
Stem Cell Transplantation
1
Peripheral Blood Stem Cell Transplantation
1
Methotrexate
1
Mesna
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
×
Azacitidine
×
30 days
×
Clear all
No trials found.